Pages that link to "Q80672548"

The following pages link to Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis (Q80672548):

Displaying 25 items.

• Effects of tempol and redox-cycling nitroxides in models of oxidative stress (Q24595411) (← links)
• Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth (Q30457642) (← links)
• Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat (Q33501717) (← links)
• NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy (Q33632781) (← links)
• Role of IL-6 in angiotensin II-induced retinal vascular inflammation (Q33845139) (← links)
• Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4. (Q33869840) (← links)
• The pathogenesis of early retinal changes of diabetic retinopathy (Q34149599) (← links)
• Brain renin-angiotensin—A new look at an old system (Q34202448) (← links)
• Angiotensin II-related hypertension and eye diseases (Q34251889) (← links)
• Endoplasmic reticulum stress and inflammation: mechanisms and implications in diabetic retinopathy (Q35928460) (← links)
• Downregulating p22phox ameliorates inflammatory response in Angiotensin II-induced oxidative stress by regulating MAPK and NF-κB pathways in ARPE-19 cells (Q36101886) (← links)
• Retinol-binding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor kappa B-dependent and retinol-independent mechanism (Q36435170) (← links)
• Adeno-Associated Virus Overexpression of Angiotensin-Converting Enzyme-2 Reverses Diabetic Retinopathy in Type 1 Diabetes in Mice. (Q36990241) (← links)
• NOX enzymes as novel targets for drug development (Q37176104) (← links)
• Role of NADPH oxidase in retinal vascular inflammation. (Q37233106) (← links)
• Alterations to the Blood–Retinal Barrier in Diabetes: Cytokines and Reactive Oxygen Species (Q37835837) (← links)
• Anti-inflammatory therapy for diabetic retinopathy. (Q37873482) (← links)
• Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model (Q37965160) (← links)
• Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies (Q38019841) (← links)
• Molecular mechanisms of diabetic retinopathy: potential therapeutic targets (Q38463463) (← links)
• Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-(1-12) axis in the Pathogenesis of Diabetic Retinopathy (Q39238324) (← links)
• Renin-Angiotensin system hyperactivation can induce inflammation and retinal neural dysfunction (Q42098043) (← links)
• Renin-angiotensin system involvement in the oxidative stress-induced neurodegeneration of cultured retinal ganglion cells (Q46697474) (← links)
• Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats (Q51034962) (← links)
• Renal and cerebral RAS interaction contributes to diabetic kidney disease. (Q64963375) (← links)